1. Home
  2. ECL vs COR Comparison

ECL vs COR Comparison

Compare ECL & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ecolab Inc.

ECL

Ecolab Inc.

N/A

Current Price

$284.61

Market Cap

77.5B

ML Signal

N/A

Logo Cencora Inc.

COR

Cencora Inc.

N/A

Current Price

$353.68

Market Cap

68.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ECL
COR
Founded
1923
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Other Pharmaceuticals
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.5B
68.5B
IPO Year
2007
2001

Fundamental Metrics

Financial Performance
Metric
ECL
COR
Price
$284.61
$353.68
Analyst Decision
Buy
Buy
Analyst Count
16
13
Target Price
$317.40
$395.23
AVG Volume (30 Days)
1.3M
982.7K
Earning Date
05-18-2026
05-06-2026
Dividend Yield
1.03%
0.67%
EPS Growth
N/A
5.71
EPS
7.28
2.87
Revenue
$16,081,200,000.00
$321,332,819,000.00
Revenue This Year
$8.56
$8.97
Revenue Next Year
$4.84
$6.76
P/E Ratio
$38.76
$124.57
Revenue Growth
2.16
9.31
52 Week Low
$229.39
$251.94
52 Week High
$309.27
$377.54

Technical Indicators

Market Signals
Indicator
ECL
COR
Relative Strength Index (RSI) 38.23 44.65
Support Level $278.38 $331.73
Resistance Level $307.90 $376.45
Average True Range (ATR) 5.86 7.17
MACD -3.65 -1.63
Stochastic Oscillator 26.76 10.19

Price Performance

Historical Comparison
ECL
COR

About ECL Ecolab Inc.

Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management solutions across its end markets. The company has a strong hold on the US market and is growing its presence abroad.

About COR Cencora Inc.

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: